OTCM
MDBIF
Market cap82mUSD
May 06, Last price
0.00USD
Name
Medibio Ltd
Chart & Performance
P/E
—
P/S
19.16
EPS
—
Div Yield, %
—
Shrs. gr., 5y
94.42%
Rev. gr., 5y
-35.96%
Revenues
889k
+3,926.59%
Net income
-1m
L-59.71%
CFO
-848k
L-8.99%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medibio Limited is a health technology firm dedicated to the identification and screening of mental health conditions, serving clients in Australia and the United States. The company provides mental well-being programs for corporations through its corporate health product line and also innovates solutions for the healthcare provider market. Founded in 1987, the enterprise was initially known as BioProspect Limited before rebranding to Medibio Limited in November 2014. Its headquarters are situated in Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||